Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

NCT03331341 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Classical Hodgkin Lymphoma

Interventions

DRUG: Dacarbazine
DRUG: Doxorubicin Hydrochloride
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
DRUG: Vinblastine

Sponsor

University of Washington